Schrodinger SDGR 深 沪
等待开盘 02-05 09:30:00 美东时间
13.36
-0.020
-0.15%
华盛通- 最 高13.46
- 今 开13.30
- 成交量 144.44万股
- 最 低 12.89
- 昨 收 13.38
- 总市值 9.84亿
- 52周最高 28.47
- 市盈率 静 --
- 换手率 1.96%
- 52周最低 12.89
- 委 比 -71.57%
- 总股本 7366.47万
- 历史最高 117.00
- 量 比 0.85
- 振 幅 4.26%
- 历史最低 12.89
- 每 手 1
- 风险率 2.73%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多AI-Native Data Core Triggers Multi-Trillion Dollar Healthcare Structural Shift
Issued on behalf of VentriPoint Diagnostics Ltd. VANCOUVER, BC, Jan. 29, 2026 /PRNewswire/ -- Equity-Insider.com News Commentary – The global AI medical imaging market exploded to a staggeri...
01-29 22:25
2026年展望 | 不止脑机接口！AI巨头开辟医疗“新战场”，这些相关标的值得提前了解
不止脑机接口！AI巨头扎堆布局医疗赛道，技术突破+需求爆发双轮驱动！这22家潜力公司名单抢先看，阿里健康开年已暴涨50%>>
01-14 11:52
美股大行评级 | 潜在涨幅197.4%！奥麦罗制药获HC Wainwright升目标价至40美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持奥麦罗制药"买入"评级，目标价从20美元升至40美元；HC Wainwright & Co.：维持Cullinan Therapeutics"买入"评级，目标价从26美元升至27美元
01-09 20:22
美股大行评级 | 瑞银上调美光科技目标价从300美元升至400美元；Freedom上调百度目标价从120美元升至160美元
今日重点评级关注：Needham：维持Vaxcyte"买入"评级，目标价从90美元升至110美元；Citizens: 维持LGI Homes"跑赢大市"评级，目标价从85美元升至95美元
01-08 18:33
UBS Initiates Coverage On Schrodinger with Neutral Rating, Announces Price Target of $18
UBS analyst Michael Yee initiates coverage on Schrodinger (NASDAQ:SDGR) with a Neutral rating and announces Price Target of $18.
01-08 04:29
美股大行评级 | 潜在涨幅113%！麦格理首予小马智行“跑赢大市"评级目标价29美元；Roth Capital下调好市多至"卖出"，目标价从906美元降至769美元
今日重点评级关注：HC Wainwright & Co.：维持BioCryst Pharma"买入"评级，目标价从30美元升至32美元；TD Cowen：上调Milestone Pharmaceuticals评级至"买入"，目标价8美元
2025-12-16 09:36
B of A Securities Upgrades Schrodinger to Buy, Maintains Price Target to $24
B of A Securities analyst Michael Ryskin upgrades Schrodinger (NASDAQ:SDGR) from Neutral to Buy and maintains the price target from $24 to $24.
2025-12-15 19:47
Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions
Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, Dec. 9, 2025 /PRNewswire/ -- Equity Insider News Commentary – Traditional pharmaceutical strategies are giving ground as breakthrou...
2025-12-10 00:57
Copernic Catalysts Surpasses Final Technical Milestone For Its Jointly-Developed Ammonia Synthesis Catalyst With Schrodinger
Copernic Catalysts, Inc. (Copernic) today announced that, in collaboration with Schrödinger, Inc. (Nasdaq: SDGR), the companies have surpassed the final technical milestone for their jointly-developed ammonia synthesis
2025-10-30 19:38
